JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M303057200 on October 28, 2003

J. Biol. Chem., Vol. 279, Issue 2, 831-836, January 9, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/2/831    most recent
M303057200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsson, S. L.
Right arrow Articles by Björkegren, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, S. L.
Right arrow Articles by Björkegren, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Low Density Lipoprotein Receptor Prevents Secretion of Dense ApoB100-containing Lipoproteins from the Liver*

Sofia L. Larsson, Josefin Skogsberg, and Johan Björkegren{ddagger}

From the Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institutet, Karolinska Hospital, 171 76 Stockholm, Sweden

The assembly and secretion of very low density lipoproteins (VLDL) require microsomal triglyceride transfer protein (MTP). Recent evidence also suggests a role for the low density lipoprotein (LDL) receptor in this process. However, the relative importance of MTP in the two steps of VLDL assembly and the specific role of the LDL receptor still remain unclear. To further investigate the role of MTP and the LDL receptor in VLDL assembly, we bred mice harboring "floxed" Mttp alleles (Mttpflox/flox) and a Cre transgene on a low-density lipoprotein receptor-deficient background to generate mice with double deficiency in the liver (Ldlr–/– Mttp{Delta}/{Delta}). In contrast to the plasma of Ldlr+/+ Mttp{Delta}/{Delta} mice, the plasma of Ldlr–/– Mttp{Delta}/{Delta} mice contained apoB100. Accordingly, Ldlr–/– Mttp{Delta}/{Delta} but not Ldlr+/+ Mttp{Delta}/{Delta} hepatocytes secreted apoB100-containing lipoprotein particles. The secreted lipoproteins were of LDL and HDL sizes but no VLDL-sized lipoproteins could be detected. These findings indicate that hepatic LDL receptors function as "gatekeepers" targeting dense apoB100-containing lipoproteins for degradation. In addition, these results suggest that very low levels of MTP are insufficient to mediate the second step but sufficient for the first step of VLDL assembly.


Received for publication, March 25, 2003 , and in revised form, October 28, 2003.

* This work was support by grants from the Swedish Research Council and the Swedish Heart-Lung Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institutet, Karolinska Hospital, 171 76 Stockholm, Sweden. Tel.: 46-8-51770314; Fax: 46-8-311298; E-mail: johan.bjorkegren{at}ks.se.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. A. Blasiole, A. T. Oler, and A. D. Attie
Regulation of ApoB Secretion by the Low Density Lipoprotein Receptor Requires Exit from the Endoplasmic Reticulum and Interaction with ApoE or ApoB
J. Biol. Chem., April 25, 2008; 283(17): 11374 - 11381.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xie, J. Luo, S. Kennedy, and N. O. Davidson
Conditional Intestinal Lipotoxicity in Apobec-1-/- Mttp-IKO Mice: A SURVIVAL ADVANTAGE FOR MAMMALIAN INTESTINAL APOLIPOPROTEIN B mRNA EDITING
J. Biol. Chem., November 9, 2007; 282(45): 33043 - 33051.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Dashti, M. Manchekar, Y. Liu, Z. Sun, and J. P. Segrest
Microsomal Triglyceride Transfer Protein Activity Is Not Required for the Initiation of Apolipoprotein B-containing Lipoprotein Assembly in McA-RH7777 Cells
J. Biol. Chem., September 28, 2007; 282(39): 28597 - 28608.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xie, E. P. Newberry, S. G. Young, S. Robine, R. L. Hamilton, J. S. Wong, J. Luo, S. Kennedy, and N. O. Davidson
Compensatory Increase in Hepatic Lipogenesis in Mice with Conditional Intestine-specific Mttp Deficiency
J. Biol. Chem., February 17, 2006; 281(7): 4075 - 4086.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Li, P. Stillemark-Billton, C. Beck, P. Bostrom, L. Andersson, M. Rutberg, J. Ericsson, B. Magnusson, D. Marchesan, A. Ljungberg, et al.
Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL
J. Lipid Res., January 1, 2006; 47(1): 67 - 77.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-C. Jiang, Z. Li, R. Liu, X. P. Yang, M. Pan, L. Lagrost, E. A. Fisher, and K. J. Williams
Phospholipid Transfer Protein Deficiency Impairs Apolipoprotein-B Secretion from Hepatocytes by Stimulating a Proteolytic Pathway through a Relative Deficiency of Vitamin E and an Increase in Intracellular Oxidants
J. Biol. Chem., May 6, 2005; 280(18): 18336 - 18340.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. Stillemark-Billton, C. Beck, J. Boren, and S.-O. Olofsson
Relation of the size and intracellular sorting of apoB to the formation of VLDL 1 and VLDL 2
J. Lipid Res., January 1, 2005; 46(1): 104 - 114.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. J. Whitfield, P. H. R. Barrett, F. M. van Bockxmeer, and J. R. Burnett
Lipid Disorders and Mutations in the APOB Gene
Clin. Chem., October 1, 2004; 50(10): 1725 - 1732.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. D. Attie
The Mystery of PCSK9
Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1337 - 1339.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.